SCHEMBL5741331

SCHEMBL5741331

O=C(O)c1c(NC(=O)C2CC2)sc2ccccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC1 P33527 2/20 0.57
ABCG2 Q9UNQ0 1/20 0.54
ACLY P53396 1/20 0.50
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
GAA P10253 3/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
MAPT P10636 2/20 0.44
GFER P55789 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP2C19 P33261 1/20 0.43
HPGD P15428 2/20 0.42
FABP4 P15090 2/20 0.42
FABP5 Q01469 2/20 0.42
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5460557 0.87 FLT3 (0.51) ABCC1ABCG2NPC1RAB9ASMN1; SMN2
SCHEMBL5449307 0.85 NPC1 (0.46) ABCC1ABCG2NPC1RAB9ASMN1; SMN2
SCHEMBL12903924 0.81 MAPT (0.60) NPC1RAB9ASMN1; SMN2GAAKMT2A
SCHEMBL8329259 0.79 ABCC1 (0.63) ABCC1ABCG2ACLYGAAMAPT
SCHEMBL2210016 0.73 ABCC1 (0.63) ABCC1ABCG2ACLYNPC1RAB9A
SCHEMBL5450627 0.72 AURKA (0.50) NPC1RAB9ASMN1; SMN2GAAMEN1
SCHEMBL3497629 0.72 ABCC1 (0.55) ABCC1ABCG2ACLYNPC1RAB9A
SCHEMBL21250173 0.72 MEN1 (0.60) ABCC1ABCG2ACLYSMN1; SMN2MEN1
SCHEMBL3498296 0.72 ABCC1 (0.77) ABCC1ABCG2ACLYNPC1RAB9A
SCHEMBL16817586 0.71 ABCC1 (0.41) ABCC1ABCG2ACLYNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670804-A2 HETEROBICYCLIC COMPOUNDS AS PHARMACEUTICALLY ACTIVE AGENTS GPC Biotech AG (DE) 2006-06-21 EP disclosed
WO-2005023818-A2 HETEROBICYCLIC COMPOUNDS AS PHARMACEUTICALLY ACTIVE AGENTS GPC BIOTECH AG (DE) 2005-03-17 WO disclosed